Table 1 Patient characteristics
From: Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma
| Â | Exploratory phase | Validation phase | ||
|---|---|---|---|---|
| Â | RCC | HC | RCC | HC |
N | 15 | 12 | 90 | 35 |
Sex | Â | Â | Â | Â |
male | 10 | 10 | 56 | 26 |
female | 5 | 2 | 34 | 9 |
Age | Â | Â | Â | Â |
median | 62 | 61 | 66 | 63 |
range | 53-73 | 54-69 | 36-85 | 51-70 |
Histology | Â | Â | Â | Â |
ccRCC | 15 | 73 | ||
pRCC | 0 | 8 | ||
chRCC | 0 | 9 | ||
Pathological stage | Â | Â | Â | Â |
pT1 | 6 | 50 | ||
pT2 | 0 | 14 | ||
pT3 | 9 | 23 | ||
pT4 | 0 | 3 | ||
vascular invasion | 5 | 16 | ||
lymph nodes metastatis | 0 | 6 | ||
distant metastasis | 3 | 18 | ||
Fuhrman grade | Â | Â | Â | Â |
G1 | 3 | 20 | ||
G2 | 7 | 39 | ||
G3 | 4 | 23 | ||
G4 | 1 | 8 | ||